These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 3102205)

  • 1. Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.
    Monk JP; Clissold SP
    Drugs; 1987 Jan; 33(1):1-30. PubMed ID: 3102205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G; Hopkins A; Akbar FA
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease.
    Wilson DE
    Am J Med; 1987 Jul; 83(1A):2-8. PubMed ID: 3113241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enprostil. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.
    Goa KL; Monk JP
    Drugs; 1987 Nov; 34(5):539-59. PubMed ID: 3121276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misoprostol and gastroduodenal mucosal protection (cytoprotection).
    Wilson DE
    Postgrad Med J; 1988; 64 Suppl 1():7-11. PubMed ID: 3138683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misoprostol: a prostaglandin E1 analog with antisecretory and cytoprotective properties.
    Jones JB; Bailey RT
    DICP; 1989 Apr; 23(4):276-82. PubMed ID: 2499129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of misoprostol clinical experience.
    Herting RL; Nissen CH
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):47S-54S. PubMed ID: 3080288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misoprostol in peptic ulcer disease.
    Watkinson G; Akbar FA
    Prostaglandins; 1987; 33 Suppl():78-92. PubMed ID: 3122278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misoprostol: a prostaglandin E1 analogue.
    Garris RE; Kirkwood CF
    Clin Pharm; 1989 Sep; 8(9):627-44. PubMed ID: 2507215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1.
    Agrawal NM; Saffouri B; Kruss DM; Callison DA; Dajani EZ
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):164S-170S. PubMed ID: 3932050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
    Thomson AB; Mahachai V
    Clin Invest Med; 1987 May; 10(3):152-70. PubMed ID: 2887321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misoprostol: a prostaglandin for peptic ulcer.
    DiPalma JR
    Am Fam Physician; 1989 Aug; 40(2):217-9. PubMed ID: 2502901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy and prevention of peptic lesions by prostaglandins].
    Müller P; Dammann HG; Simon B
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():166-74. PubMed ID: 3116777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of prostanoids in the treatment of gastric ulcer.
    Rachmilewitz D
    Clin Invest Med; 1987 May; 10(3):238-42. PubMed ID: 3113800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin.
    Roth S; Agrawal N; Mahowald M; Montoya H; Robbins D; Miller S; Nutting E; Woods E; Crager M; Nissen C
    Arch Intern Med; 1989 Apr; 149(4):775-9. PubMed ID: 2495779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Misoprostol and de-nol in the treatment of patients with cimetidine-resistant stomach ulcer].
    Stasiewicz J; Raimer M; Kozuszyńska M; Szałaj W; Slezak L
    Pol Arch Med Wewn; 1989 Jan; 81(1):21-9. PubMed ID: 2515527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study.
    Brand DL; Roufail WM; Thomson AB; Tapper EJ
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):147S-158S. PubMed ID: 3932048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy of peptic ulcer. What is coming up?].
    Müller P; Dammann HG; Simon B; Kommerell B
    Leber Magen Darm; 1987 Feb; 17(1):50-4. PubMed ID: 3104707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspective on the gastric antisecretory effects of misoprostol in man.
    Dajani EZ
    Prostaglandins; 1987; 33 Suppl():68-77. PubMed ID: 3122277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.